PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19
Conditions:   COVID-19;   COVID-19 Pandemic;   COVID-19 Respiratory Infection;   SARS-CoV2 Infection;   Cytokine Release Syndrome Interventions:   Drug: Galactomannan;   Drug: PLACEBO Sponsors:   Pharmalectin Inc;   ALKE RESEARCH PRIVATE LIMITED;   Research Consultancy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2021 Category: Research Source Type: clinical trials

PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19
Conditions:   COVID-19;   COVID-19 Pandemic;   COVID-19 Respiratory Infection;   SARS-CoV2 Infection;   Cytokine Release Syndrome Interventions:   Drug: Galactomannan;   Drug: PLACEBO Sponsors:   Bioxytran Inc.;   ALKE RESEARCH PRIVATE LIMITED;   Research Consultancy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2021 Category: Research Source Type: clinical trials

Rheumatoid Arthritis, Planned Behav ıor Theory And Nurse Counselıng
Condition:   Rheumatoid Arthritis Intervention:   Behavioral: TRAINING AND CONSULTANCY Sponsor:   Hasan Kalyoncu University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2021 Category: Research Source Type: clinical trials